FPRX Stock Summary

• Five Prime Therapeutics Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 10.51% of US listed stocks.
• Revenue growth over the past 12 months for Five Prime Therapeutics Inc comes in at -70.01%, a number that bests merely 1.93% of the US stocks we're tracking.
• In terms of volatility of its share price, FPRX is more volatile than 95.22% of stocks we're observing.
• Stocks with similar financial metrics, market capitalization, and price volatility to Five Prime Therapeutics Inc are BCRX, CTMX, ATHX, INO, and CNAT.
• Visit FPRX's SEC page to see the company's official filings. To visit the company's web site, go to www.fiveprime.com.